Updated on 24 February 2015
Georgia State and Cisen will conduct clinical trials and develop a product for the Chinese market
Singapore: Georgia State University has inked a pact with Cisen pharmaceuticals in China to develop cancer fighting compounds for leukemia. The molecules are designed by Georgia State researcher Dr Binghe Wang, in collaboration with Professor Muxiang Zhou of Emory University, a cancer biologist.
As per the agreement terms, Cisen Pharmaceutical will continue research collaboration with Dr Wang and support research activity in his lab. The team said that though the compounds are developed for leukemia they can be used to treat other cancers too.
Through the partnership, Georgia State and Cisen will conduct clinical trials and develop a product for the Chinese market. Georgia State retains the right to partner with companies worldwide to develop the product for the United States and other markets.
The university is interested in engaging in additional partnerships, according to Dr Chester Bisbee, associate vice president and director of the Office of Technology Licensing and Commercialization.
Dr Bisbee mentioned, "We are delighted to collaborate with Cisen and we look forward to our partnership and potentially developing a cancer-fighting drug for the market that could save lives and reduce the suffering caused by cancer."